Matches in Wikidata for { <http://www.wikidata.org/entity/Q91016693> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q91016693 description "article scientifique publié en 2018" @default.
- Q91016693 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q91016693 description "scientific article published on 09 September 2018" @default.
- Q91016693 description "wetenschappelijk artikel" @default.
- Q91016693 description "наукова стаття, опублікована у вересні 2018" @default.
- Q91016693 name "FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer" @default.
- Q91016693 name "FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer" @default.
- Q91016693 type Item @default.
- Q91016693 label "FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer" @default.
- Q91016693 label "FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer" @default.
- Q91016693 prefLabel "FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer" @default.
- Q91016693 prefLabel "FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer" @default.
- Q91016693 P1433 Q91016693-2458321D-7AC5-4CB7-836F-2885FC1DB496 @default.
- Q91016693 P1476 Q91016693-7BC63CB6-E809-46E5-9DA8-F7250A1454CA @default.
- Q91016693 P2093 Q91016693-0D02DA57-CF25-46A6-B155-664379C405FD @default.
- Q91016693 P2093 Q91016693-398D8B29-FBF2-492A-845F-0E8FC11C76EB @default.
- Q91016693 P2093 Q91016693-502A7D93-D93C-4E0D-B60D-3006C9D44AEC @default.
- Q91016693 P2093 Q91016693-5BB251FB-E9D9-4229-B406-60FA893716FE @default.
- Q91016693 P2093 Q91016693-930BE184-D34B-44BE-9B0B-AC1DCD7A3D5F @default.
- Q91016693 P2093 Q91016693-97C7237E-8AF6-4683-9597-E4BCE1DA0642 @default.
- Q91016693 P2093 Q91016693-BD0A27FA-1498-47F9-A018-269527E279C8 @default.
- Q91016693 P2093 Q91016693-DC281F0F-B0D2-42DD-A431-F957DBFA8288 @default.
- Q91016693 P2093 Q91016693-EE08909A-0617-4F03-81D4-E0A8C7989E2B @default.
- Q91016693 P2093 Q91016693-F672A54A-1FC7-4B6C-9546-357B17619F02 @default.
- Q91016693 P2860 Q91016693-5D4C9813-A6F5-413A-9F3F-C3FACDCC5D1E @default.
- Q91016693 P304 Q91016693-561993C2-4836-4052-9F0D-516839B08107 @default.
- Q91016693 P31 Q91016693-8737BBB1-9950-426A-981A-8C2A59681092 @default.
- Q91016693 P356 Q91016693-C7D0AD8B-0388-4DFD-A0C0-6EAC79D7A47F @default.
- Q91016693 P433 Q91016693-0E9EF277-ABD9-4455-91B6-7F47B08CE565 @default.
- Q91016693 P478 Q91016693-11088DBE-D62B-4EB2-A8AC-8BF5F9951978 @default.
- Q91016693 P50 Q91016693-62C05281-D95D-404F-B77A-7A46CC13C986 @default.
- Q91016693 P50 Q91016693-B2093595-204F-400F-8012-5409ED0A9C56 @default.
- Q91016693 P577 Q91016693-203153EA-CB7F-406F-8D4C-805A5D4A470C @default.
- Q91016693 P698 Q91016693-7206903E-E88A-42B3-835D-2EE2D2A79370 @default.
- Q91016693 P921 Q91016693-FE3C637F-3BC3-49B9-A3BC-BC52FB7D1C6A @default.
- Q91016693 P356 BJU.14525 @default.
- Q91016693 P698 30120861 @default.
- Q91016693 P1433 Q4835773 @default.
- Q91016693 P1476 "FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer" @default.
- Q91016693 P2093 "Danijel Sikic" @default.
- Q91016693 P2093 "Markus Eckstein" @default.
- Q91016693 P2093 "Maximilian Burger" @default.
- Q91016693 P2093 "Philipp Erben" @default.
- Q91016693 P2093 "Ralph M Wirtz" @default.
- Q91016693 P2093 "Robert Stoehr" @default.
- Q91016693 P2093 "Sebastien Rinaldetti" @default.
- Q91016693 P2093 "Stefan Denzinger" @default.
- Q91016693 P2093 "Thomas S Worst" @default.
- Q91016693 P2093 "Wolfgang Otto" @default.
- Q91016693 P2860 Q35163008 @default.
- Q91016693 P304 "187-196" @default.
- Q91016693 P31 Q13442814 @default.
- Q91016693 P356 "10.1111/BJU.14525" @default.
- Q91016693 P433 "1" @default.
- Q91016693 P478 "123" @default.
- Q91016693 P50 Q88106610 @default.
- Q91016693 P50 Q89782316 @default.
- Q91016693 P577 "2018-09-09T00:00:00Z" @default.
- Q91016693 P698 "30120861" @default.
- Q91016693 P921 Q504775 @default.